Search company, investor...
European Academy of Neurology company logo

European Academy of Neurology

Founded Year


About European Academy of Neurology

European Academy of Neurology (EAN) is a non-profit organization. The organization unites and supports neurologists. The organization provides practical and useful resources for all members, including online educational resources, schools, and courses. It was founded in 2014 and is based in Vienna, Austria.

Headquarters Location

Breite Gasse 4/7

Vienna, 1070,


Missing: European Academy of Neurology's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: European Academy of Neurology's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest European Academy of Neurology News

European Academy of Neurology (EAN 2022) – Braintale to Present Promising Results on Amyotrophic Lateral Sclerosis Biomarker Potential of Its Digital Platform

Jun 27, 2022

June 27, 2022 04:45 AM Eastern Daylight Time STRASBOURG, France--( BUSINESS WIRE )--Braintale, a medtech deciphering white matter, spin off from the Paris Greater Hospitals has presented the results of SOM-ALS sub-study in amyotrophic lateral sclerosis (ALS) during the European Academy of Neurology (EAN 2022) congress both in Vienna (Austria) and digitally from June 25th to 28th, 2022. Long underestimated in neurosciences, white matter, which represents 80% of the human brain, plays a key role in its proper functioning, development, and aging, whether normal or pathological. Accordingly, Braintale has been developing, since its inception in 2018, non-invasive, accessible, effective and clinically validated measurement and prediction tools for physicians treating patients suffering from brain diseases. The Braintale platform includes AI-processed CE-marked digital solutions, deployed across two modules. Brainquant enables white matter quantification and brainScore-coma powers clinical prediction. ALS is characterized by a progressive and irreversible degeneration of motor neurons that allow the body’s movements to be controlled. Patients with ALS gradually experience symptoms such as cramps, muscle contractions, and strain. Over time, within two to five years of initial diagnosis, the whole body is paralyzed, including the respiratory muscles, resulting in inevitable death, affecting 50,000 patients in Europe*. Today, doctors deplore a late and long journey for confirmed diagnosis, occurring on average one year after the first symptoms, thus delaying the time to initiate symptomatic care, largely suboptimal. Conducted under the supervision of Dr Pierre-François Pradat, neurologist at the Pitié-Salpêtrière Hospital, the study originated from SOM-ALS Inserm-sponsored trial (NCT03694132).The poster is entitled Evaluation of a clinically validated MRI analysis web platform for obtaining biomarkers in ALS and has been presented on June 26th, at 12:30 pm CET by Hugo Kermorvant. The preliminary study offers encouraging perspective in the diagnosis and disease monitoring for ALS patients. “The presented exploratory study shows the excellent potential of both diagnostics and disease monitoring for ALS patients based on powerful neuroimaging approaches as developed by Braintale” comments Dr Pradat. “The platform can provide proxies of upper motoneuron degeneration in ALS patients, with or without clinical signs and could be implemented in a clinical setting for diagnosis and decision-making or surrogate endpoint in clinical trials”. "EAN presented data opens additional perspective for Braintale to change the game in rare neurological conditions such as ALS as a proof-of-concept of the relevance of white matter assessment in the diagnostic and monitoring of patients ", comments Vincent Perlbarg, co-founder and CSO of BrainTale. “The whole team is committed to developing relevant solutions to enable better care for patients suffering from this devastating disease” he adds.

European Academy of Neurology Frequently Asked Questions (FAQ)

  • When was European Academy of Neurology founded?

    European Academy of Neurology was founded in 2014.

  • Where is European Academy of Neurology's headquarters?

    European Academy of Neurology's headquarters is located at Breite Gasse 4/7, Vienna.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.